| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Sr. VP &Chief Comm. Officer | Sr. VP, Corp. Partnerships
2 companies
Abercrombie George B serves as a Sr. VP &Chief Comm. Officer at INVA and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 12 sells. Those positions are worth an estimated $4.0M at current prices.
Historically, Abercrombie George B's trades have earned a middling insider score of 68/100 across 8 rated trades. Over a 12-month horizon, 87.5% of those trades were profitable, with an average 12-month return of +22.7%.
The biggest single holding is INVA (~$4.0M) as Sr. VP &Chief Comm. Officer. The recent filings there lean toward selling, a net 29,215 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 18, 2022 | BCRX Biocryst Pharmaceuticals Inc | Director | Sale+OE | 5,000 | $11.04 | $55,200.00 | -100% | +7.1% | -29.3% | |
| Feb 15, 2022 | BCRX Biocryst Pharmaceuticals Inc | Director | Sale+OE | 5,000 | $18.50 | $92,500.00 | -100% | -54.7% | -45.8% | |
| Nov 15, 2021 | BCRX Biocryst Pharmaceuticals Inc | Director | Sale+OE | 5,000 | $12.27 | $61,350.00 | -100% | +50.0% | +11.5% | |
| Sep 15, 2021 | BCRX Biocryst Pharmaceuticals Inc | Director | Sale+OE | 5,000 | $15.06 | $75,300.00 | -100% | -24.2% | -14.9% | |
| Sep 10, 2021 | BCRX Biocryst Pharmaceuticals Inc | Director | Sale+OE | 74,000 | $15.09 | $1,116,660.00 | -100% | -22.5% | -11.5% | |
| Jul 15, 2021 | BCRX Biocryst Pharmaceuticals Inc | Director | Sale+OE | 5,000 | $15.69 | $78,450.00 | -62.5% | -5.1% | -26.3% | |
| May 24, 2021 | BCRX Biocryst Pharmaceuticals Inc | Director | Sale+OE | 6,667 | $13.90 | $92,671.30 | -69.0% | +11.0% | -37.1% | |
| May 10, 2021 | BCRX Biocryst Pharmaceuticals Inc | Director | Sell | 7,000 | $12.70 | $88,900.00 | -70.0% | +47.9% | -27.9% | |
| Aug 21, 2018 | INVA Innoviva, Inc. | Sr. VP &Chief Comm. Officer | Sell | 8,000 | $14.11 | $112,840.00 | -2.7% | - | - | |
| May 21, 2018 | INVA Innoviva, Inc. | Sr. VP &Chief Comm. Officer | Sell | 8,000 | $14.40 | $115,202.40 | -2.6% | - | - |